Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.87
-0.04 (-2.09%)
At close: Jun 13, 2025, 3:59 PM
1.86
-0.53%
After-hours: Jun 13, 2025, 04:00 PM EDT
-2.09% (1D)
| Bid | 1.8 |
| Market Cap | 139.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -36.55M |
| EPS (ttm) | -0.58 |
| PE Ratio (ttm) | -3.22 |
| Forward PE | -3.91 |
| Analyst | Hold |
| Ask | 2.02 |
| Volume | 88,800 |
| Avg. Volume (20D) | 126,560 |
| Open | 1.90 |
| Previous Close | 1.91 |
| Day's Range | 1.87 - 1.98 |
| 52-Week Range | 1.12 - 4.20 |
| Beta | 0.94 |
Analyst Forecast
According to 0 analyst ratings, the average rating for IKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
-13.14%
Inhibikase Therapeutics shares are trading lower. ...
Unlock content with
Pro Subscription
7 months ago
+3.6%
Inhibikase Therapeutics shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced an $8 price target.
